BCM
BMY icon

Beddow Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Beddow Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,875
Closed -$297K – 55
2025
Q1 		$297K Sell
4,875
-8,005
-62% -$467K 0.11% 48
2024
Q4 		$728K Sell
12,880
-2,120
-14% -$118K 0.3% 42
2024
Q3 		$776K Sell
15,000
-19,055
-56% -$894K 0.32% 40
2024
Q2 		$1.41M Buy
34,055
+1,400
+4% +$62.6K 0.62% 33
2024
Q1 		$1.77M Buy
32,655
+3,749
+13% +$191K 0.77% 34
2023
Q4 		$1.48M Sell
28,906
-28,323
-49% -$1.49M 0.69% 32
2023
Q3 		$3.32M Sell
57,229
-1,481
-3% -$90.7K 1.62% 28
2023
Q2 		$3.75M Buy
58,710
+125
+0.2% +$8.38K 1.91% 27
2023
Q1 		$4.06M Buy
58,585
+750
+1% +$52.9K 2.03% 26
2022
Q4 		$4.16M Sell
57,835
-175
-0.3% -$13.2K 2.13% 23
2022
Q3 		$4.12M Buy
58,010
+500
+0.9% +$36.3K 2.5% 17
2022
Q2 		$4.43M Buy
57,510
+2,260
+4% +$172K 2.61% 16
2022
Q1 		$4.04M Buy
55,250
+2,025
+4% +$136K 2.13% 22
2021
Q4 		$3.32M Buy
53,225
+9,525
+22% +$559K 1.88% 23
2021
Q3 		$2.59M Buy
+43,700
New +$2.88M 1.55% 29
2020
Q4 		– Sell
-31,345
Closed -$1.89M – 55
2020
Q3 		$1.89M Sell
31,345
-700
-2% -$42.1K 1.62% 23
2020
Q2 		$1.88M Sell
32,045
-5,125
-14% -$307K 1.65% 24
2020
Q1 		$2.07M Sell
37,170
-2,710
-7% -$166K 1.91% 23
2019
Q4 		$2.56M Buy
39,880
+1,710
+4% +$97.9K 1.59% 28
2019
Q3 		$1.94M Sell
38,170
-230
-0.6% -$10.8K 1.22% 31
2019
Q2 		$1.74M Sell
38,400
-10,660
-22% -$497K 1% 31
2019
Q1 		$1.77M Buy
49,060
+30,005
+157% +$1.49M 0.97% 31
2018
Q4 		$360K Buy
+19,055
New +$1.02M 0.2% 38

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Beddow Capital Management's BMY Position: Q2 2025 in Review

Beddow Capital Management sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 4,875 shares — an estimated $297K sold.

Beddow Capital Management first reported a position in BMY in Q4 2018 and held it in 23 quarters. The position peaked at $4.43M in Q2 2022. 2,297 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

  • Beddow Capital Management reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
  • Beddow Capital Management sold 4,875 Bristol-Myers Squibb shares in Q2 2025, an estimated $297K.
  • Beddow Capital Management first reported a position in Bristol-Myers Squibb in Q4 2018 and held it in 23 quarters.
  • Beddow Capital Management's Bristol-Myers Squibb position peaked at $4.43M in Q2 2022.
  • 2,297 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on Beddow Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.